View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 17, 2020

Cape Biologix, Inno-3B, and PlantForm sign Covid-19 test deal

South Africa-based Cape Bio Pharms subsidiary Cape Biologix Technologies, Inno-3B, and PlantForm have signed a commercial agreement to increase the production of plant-based SARS-COV-2 antigens for a new Covid-19 antibody blood test. 

South Africa-based Cape Bio Pharms subsidiary Cape Biologix Technologies, Inno-3B, and PlantForm have signed a commercial agreement to increase the production of plant-based SARS-COV-2 antigens for a new Covid-19 antibody blood test.

According to the deal, Cape Biologix’s SARS-COV-2 antigens will be produced in plants grown by Inno-3B. PlantForm will extract, purify, and manufacture the antigens for use as the reagent in antibody test kits.

The three companies plan to provide fast, low-cost, and accurate plant-made proteins for Covid-19 monitoring and surveillance tools.

PlantForm CEO Dr Don Stewart said: “This collaboration meets a critical need for effective, low-cost and widespread serology testing to determine the prevalence of Covid-19 infection in different populations, its rate of spread and whether people who recover from it develop lasting immunity.”

Using technology initially developed by Cape Bio Pharms, Inno-3B, and PlantForm will produce the plant-based SARS-COV-2 antigens at their respective Canadian facilities in Saint-Pacôme, Quebec and Bolton in Ontario.

Cape Biologix CEO Belinda Shaw said: “It’s a simple finger-prick blood test that will detect whether a person has antibodies against the virus in their blood.

“Continuous testing of communities is essential to provide a footprint of where the disease has been, as well as peace of mind to those who simply want to know – have I had it?”

Moreover, the test can deliver results within 15 minutes.

In addition, Cape Biologix has partnered with kit manufacturers in India for rapid scale-up of production earlier next year.

The company plans to supply proteins to test kit manufacturers across various international markets, including Brazil and Canada.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network